Free Trial
NASDAQ:ATAI

atai Life Sciences (ATAI) Stock Price, News & Analysis

atai Life Sciences logo
$5.23 +0.09 (+1.75%)
Closing price 04:00 PM Eastern
Extended Trading
$5.24 +0.01 (+0.21%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About atai Life Sciences Stock (NASDAQ:ATAI)

Advanced

Key Stats

Today's Range
$5.04
$5.52
50-Day Range
$3.31
$5.61
52-Week Range
$1.03
$5.97
Volume
4.73 million shs
Average Volume
5.69 million shs
Market Capitalization
$1.22 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.25
Consensus Rating
Moderate Buy

Company Overview

atai Life Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

ATAI MarketRank™: 

atai Life Sciences scored higher than 68% of companies evaluated by MarketBeat, and ranked 331st out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    atai Life Sciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 3 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    atai Life Sciences has a consensus price target of $11.25, representing about 115.1% upside from its current price of $5.23.

  • Amount of Analyst Coverage

    atai Life Sciences has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about atai Life Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for atai Life Sciences are expected to grow in the coming year, from ($0.77) to ($0.61) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of atai Life Sciences is -7.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of atai Life Sciences is -7.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    atai Life Sciences has a P/B Ratio of 7.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about atai Life Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    13.01% of the float of atai Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    atai Life Sciences has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in atai Life Sciences has recently increased by 3.37%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    atai Life Sciences does not currently pay a dividend.

  • Dividend Growth

    atai Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.01% of the float of atai Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    atai Life Sciences has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in atai Life Sciences has recently increased by 3.37%, indicating that investor sentiment is decreasing.
  • News Sentiment

    atai Life Sciences has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for atai Life Sciences this week, compared to 3 articles on an average week.
  • Search Interest

    42 people have searched for ATAI on MarketBeat in the last 30 days. This is an increase of 40% compared to the previous 30 days.
  • MarketBeat Follows

    14 people have added atai Life Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, atai Life Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    26.80% of the stock of atai Life Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 28.41% of the stock of atai Life Sciences is held by institutions.

  • Read more about atai Life Sciences' insider trading history.
Receive ATAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for atai Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATAI Stock News Headlines

The Tiny Stock Set to Soar with Musk's AI Ambitions
The Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires in history, one tiny AI stock is flying under the radar. While you can't invest directly, we've pinpointed a stock poised to benefit immensely from his plans.tc pixel
Atai Life Sciences: Still A Decent Prospect - But Only Just
See More Headlines

ATAI Stock Analysis - Frequently Asked Questions

atai Life Sciences' stock was trading at $1.33 at the beginning of the year. Since then, ATAI shares have increased by 293.2% and is now trading at $5.23.

atai Life Sciences N.V. (NASDAQ:ATAI) issued its earnings results on Thursday, August, 14th. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.12) by $0.02. The firm had revenue of $0.72 million for the quarter.

atai Life Sciences (ATAI) raised $200 million in an initial public offering (IPO) on Friday, June 18th 2021. The company issued 14,300,000 shares at $13.00-$15.00 per share. Credit Suisse, Citigroup, Cowen and Berenberg served as the underwriters for the IPO and Cantor, RBC Capital Markets and Canaccord Genuity were co-managers.

Shares of ATAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that atai Life Sciences investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Adobe (ADBE), Arista Networks (ANET), CrowdStrike (CRWD) and ServiceNow (NOW).

Company Calendar

Last Earnings
8/14/2025
Today
10/03/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ATAI
CIK
1420529
Fax
N/A
Employees
80
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$5.00
Potential Upside/Downside
+115.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$149.27 million
Net Margins
N/A
Pretax Margin
-5,180.12%
Return on Equity
-85.43%
Return on Assets
-64.38%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
4.02
Quick Ratio
4.02

Sales & Book Value

Annual Sales
$310 thousand
Price / Sales
3,944.09
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.69 per share
Price / Book
7.58

Miscellaneous

Outstanding Shares
233,780,000
Free Float
171,126,000
Market Cap
$1.22 billion
Optionable
Optionable
Beta
1.58
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ATAI) was last updated on 10/3/2025 by MarketBeat.com Staff
From Our Partners